Jason V Coloma

Chief Executive Officer · Maze Therapeutics

Jason V Coloma (Chief Executive Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $965K of MAZE (31,908 sh across 2 lots, as filed), executed Nov 2. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 8 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.7M

shares × price, as filed

Last traded

Nov 2

Filed Nov 4

Median ADV $16.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 8 filings

Sector per market data · by filing · past 12 months

Most traded names

MAZE

Maze Therapeutics, Inc. MAZE · 0 buys · 8 sells 8 filings

Recent filings

MAZESALE Maze Therapeutics, Inc. View filing → $965K
31,908 sh across 2 lots
Exec Nov 2
Filed Nov 4 · 4:13 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $862K
31,908 sh × $27.02
Exec Oct 1
Filed Oct 2 · 4:12 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $553K
21,134 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $810K
30,304 sh × $26.71
Exec Aug 3
Filed Aug 5 · 4:08 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $908K
30,311 sh × $29.95
Exec Jul 1
Filed Jul 2 · 4:28 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $622K
23,865 sh × $26.05
Exec Jun 23
Filed Jun 24 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $160K
6,090 sh × $26.20
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $783K
30,086 sh across 2 lots
Exec May 22
Filed May 27 · 5:30 PM ET